IDEXX Laboratories, Inc. (0J8P.L)
USD 419.98
(-2.66%)
USD 419.98
(-2.66%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.25 Billion USD | 18.68% |
| 2022 | 2.74 Billion USD | 12.7% |
| 2021 | 2.43 Billion USD | 6.22% |
| 2020 | 2.29 Billion USD | 25.22% |
| 2019 | 1.83 Billion USD | 19.2% |
| 2018 | 1.53 Billion USD | -10.28% |
| 2017 | 1.71 Billion USD | 11.94% |
| 2016 | 1.53 Billion USD | 3.78% |
| 2015 | 1.47 Billion USD | 6.56% |
| 2014 | 1.38 Billion USD | 12.49% |
| 2013 | 1.23 Billion USD | 11.5% |
| 2012 | 1.1 Billion USD | 7.06% |
| 2011 | 1.03 Billion USD | 14.9% |
| 2010 | 897.14 Million USD | 10.96% |
| 2009 | 808.52 Million USD | 5.63% |
| 2008 | 765.43 Million USD | 9.01% |
| 2007 | 702.17 Million USD | 25.49% |
| 2006 | 559.56 Million USD | 14.04% |
| 2005 | 490.67 Million USD | -4.58% |
| 2004 | 514.23 Million USD | -1.46% |
| 2003 | 521.87 Million USD | 25.25% |
| 2002 | 416.65 Million USD | 11.67% |
| 2001 | 373.1 Million USD | 11.11% |
| 2000 | 335.79 Million USD | -6.78% |
| 1999 | 360.2 Million USD | -7.76% |
| 1998 | 390.5 Million USD | 3.58% |
| 1997 | 377 Million USD | 0.83% |
| 1996 | 373.9 Million USD | 19.65% |
| 1995 | 312.5 Million USD | 156.78% |
| 1994 | 121.7 Million USD | 24.18% |
| 1993 | 98 Million USD | 22.96% |
| 1992 | 79.7 Million USD | 109.19% |
| 1991 | 38.1 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.35 Billion USD | 2.87% |
| 2024 Q2 | 3.41 Billion USD | 1.83% |
| 2024 Q3 | 3.35 Billion USD | -1.88% |
| 2023 Q2 | 2.87 Billion USD | 2.22% |
| 2023 Q3 | 3.08 Billion USD | 7.51% |
| 2023 Q4 | 3.25 Billion USD | 5.62% |
| 2023 Q1 | 2.8 Billion USD | 2.24% |
| 2023 FY | 3.25 Billion USD | 18.68% |
| 2022 Q4 | 2.74 Billion USD | 4.04% |
| 2022 Q3 | 2.64 Billion USD | 1.26% |
| 2022 FY | 2.74 Billion USD | 12.7% |
| 2022 Q1 | 2.59 Billion USD | 6.38% |
| 2022 Q2 | 2.6 Billion USD | 0.56% |
| 2021 Q2 | 2.41 Billion USD | 3.64% |
| 2021 Q3 | 2.38 Billion USD | -1.09% |
| 2021 Q4 | 2.43 Billion USD | 2.16% |
| 2021 FY | 2.43 Billion USD | 6.22% |
| 2021 Q1 | 2.32 Billion USD | 1.43% |
| 2020 Q4 | 2.29 Billion USD | 12.07% |
| 2020 Q2 | 1.96 Billion USD | 3.95% |
| 2020 FY | 2.29 Billion USD | 25.22% |
| 2020 Q1 | 1.88 Billion USD | 2.93% |
| 2020 Q3 | 2.04 Billion USD | 4.42% |
| 2019 Q3 | 1.75 Billion USD | 1.58% |
| 2019 FY | 1.83 Billion USD | 19.2% |
| 2019 Q1 | 1.68 Billion USD | 9.34% |
| 2019 Q2 | 1.72 Billion USD | 2.57% |
| 2019 Q4 | 1.83 Billion USD | 4.62% |
| 2018 FY | 1.53 Billion USD | -10.28% |
| 2018 Q1 | 1.46 Billion USD | -14.24% |
| 2018 Q2 | 1.52 Billion USD | 3.48% |
| 2018 Q3 | 1.54 Billion USD | 1.57% |
| 2018 Q4 | 1.53 Billion USD | -0.46% |
| 2017 Q3 | 1.66 Billion USD | 1.97% |
| 2017 Q1 | 1.57 Billion USD | 2.7% |
| 2017 Q4 | 1.71 Billion USD | 2.64% |
| 2017 Q2 | 1.63 Billion USD | 4.14% |
| 2017 FY | 1.71 Billion USD | 11.94% |
| 2016 Q1 | 1.47 Billion USD | 0.25% |
| 2016 Q4 | 1.53 Billion USD | 2.02% |
| 2016 Q3 | 1.5 Billion USD | 0.75% |
| 2016 FY | 1.53 Billion USD | 3.78% |
| 2016 Q2 | 1.48 Billion USD | 0.72% |
| 2015 Q3 | 1.47 Billion USD | -0.01% |
| 2015 FY | 1.47 Billion USD | 6.56% |
| 2015 Q2 | 1.47 Billion USD | 3.24% |
| 2015 Q1 | 1.43 Billion USD | 3.38% |
| 2015 Q4 | 1.47 Billion USD | -0.15% |
| 2014 Q1 | 1.26 Billion USD | 2.58% |
| 2014 FY | 1.38 Billion USD | 12.49% |
| 2014 Q4 | 1.38 Billion USD | 7.25% |
| 2014 Q3 | 1.29 Billion USD | 0.58% |
| 2014 Q2 | 1.28 Billion USD | 1.65% |
| 2013 FY | 1.23 Billion USD | 11.5% |
| 2013 Q3 | 1.19 Billion USD | 2.68% |
| 2013 Q2 | 1.16 Billion USD | 2.78% |
| 2013 Q1 | 1.13 Billion USD | 2.63% |
| 2013 Q4 | 1.23 Billion USD | 2.95% |
| 2012 FY | 1.1 Billion USD | 7.06% |
| 2012 Q2 | 1.06 Billion USD | 0.59% |
| 2012 Q3 | 1.09 Billion USD | 2.44% |
| 2012 Q1 | 1.06 Billion USD | 2.94% |
| 2012 Q4 | 1.1 Billion USD | 0.94% |
| 2011 Q4 | 1.03 Billion USD | 6.36% |
| 2011 Q2 | 950.57 Million USD | 4.52% |
| 2011 Q1 | 909.47 Million USD | 1.37% |
| 2011 FY | 1.03 Billion USD | 14.9% |
| 2011 Q3 | 969.19 Million USD | 1.96% |
| 2010 Q1 | 824.28 Million USD | 1.95% |
| 2010 FY | 897.14 Million USD | 10.96% |
| 2010 Q3 | 862.29 Million USD | 3.43% |
| 2010 Q4 | 897.14 Million USD | 4.04% |
| 2010 Q2 | 833.73 Million USD | 1.15% |
| 2009 FY | 808.52 Million USD | 5.63% |
| 2009 Q1 | 770.5 Million USD | 0.66% |
| 2009 Q2 | 798.51 Million USD | 3.63% |
| 2009 Q3 | 814.88 Million USD | 2.05% |
| 2009 Q4 | 808.52 Million USD | -0.78% |
| 2008 Q2 | 764.88 Million USD | 3.8% |
| 2008 Q1 | 736.85 Million USD | 4.94% |
| 2008 FY | 765.43 Million USD | 9.01% |
| 2008 Q4 | 765.43 Million USD | -1.7% |
| 2008 Q3 | 778.69 Million USD | 1.8% |
| 2007 Q2 | 646.16 Million USD | -0.05% |
| 2007 FY | 702.17 Million USD | 25.49% |
| 2007 Q1 | 646.49 Million USD | 15.54% |
| 2007 Q3 | 674.23 Million USD | 4.34% |
| 2007 Q4 | 702.17 Million USD | 4.14% |
| 2006 Q3 | 524.97 Million USD | 4.71% |
| 2006 FY | 559.56 Million USD | 14.04% |
| 2006 Q4 | 559.56 Million USD | 6.59% |
| 2006 Q1 | 475.24 Million USD | -3.15% |
| 2006 Q2 | 501.37 Million USD | 5.5% |
| 2005 Q1 | 487.91 Million USD | -5.12% |
| 2005 Q2 | 500.25 Million USD | 2.53% |
| 2005 Q3 | 492.63 Million USD | -1.52% |
| 2005 Q4 | 490.67 Million USD | -0.4% |
| 2005 FY | 490.67 Million USD | -4.58% |
| 2004 FY | 514.23 Million USD | -1.46% |
| 2004 Q4 | 514.23 Million USD | 0.36% |
| 2004 Q3 | 512.4 Million USD | -2.06% |
| 2004 Q1 | 523.08 Million USD | 0.23% |
| 2004 Q2 | 523.2 Million USD | 0.02% |
| 2003 Q4 | 521.87 Million USD | 4.96% |
| 2003 FY | 521.87 Million USD | 25.25% |
| 2003 Q1 | 436.91 Million USD | 4.86% |
| 2003 Q2 | 465.9 Million USD | 6.64% |
| 2003 Q3 | 497.21 Million USD | 6.72% |
| 2002 Q1 | 395.36 Million USD | 5.97% |
| 2002 Q2 | 375.54 Million USD | -5.01% |
| 2002 Q3 | 410.81 Million USD | 9.39% |
| 2002 Q4 | 416.65 Million USD | 1.42% |
| 2002 FY | 416.65 Million USD | 11.67% |
| 2001 Q2 | 342.61 Million USD | 6.21% |
| 2001 Q4 | 373.1 Million USD | 2.82% |
| 2001 Q3 | 362.88 Million USD | 5.92% |
| 2001 Q1 | 322.58 Million USD | -3.93% |
| 2001 FY | 373.1 Million USD | 11.11% |
| 2000 Q2 | 376.08 Million USD | 3.95% |
| 2000 Q3 | 354.36 Million USD | -5.78% |
| 2000 FY | 335.79 Million USD | -6.78% |
| 2000 Q4 | 335.79 Million USD | -5.24% |
| 2000 Q1 | 361.8 Million USD | 0.44% |
| 1999 Q1 | 387.6 Million USD | -0.74% |
| 1999 Q2 | 409.2 Million USD | 5.57% |
| 1999 FY | 360.2 Million USD | -7.76% |
| 1999 Q3 | 383.1 Million USD | -6.38% |
| 1999 Q4 | 360.2 Million USD | -5.98% |
| 1998 Q4 | 390.5 Million USD | 2.66% |
| 1998 Q1 | 375.5 Million USD | -0.4% |
| 1998 Q2 | 385.6 Million USD | 2.69% |
| 1998 Q3 | 380.4 Million USD | -1.35% |
| 1998 FY | 390.5 Million USD | 3.58% |
| 1997 Q3 | 375 Million USD | -0.77% |
| 1997 Q4 | 377 Million USD | 0.53% |
| 1997 Q1 | 372.7 Million USD | -0.32% |
| 1997 FY | 377 Million USD | 0.83% |
| 1997 Q2 | 377.9 Million USD | 1.4% |
| 1996 Q4 | 373.9 Million USD | 4.85% |
| 1996 FY | 373.9 Million USD | 19.65% |
| 1996 Q1 | 324.5 Million USD | 3.84% |
| 1996 Q2 | 348.8 Million USD | 7.49% |
| 1996 Q3 | 356.6 Million USD | 2.24% |
| 1995 Q1 | 135.9 Million USD | 11.67% |
| 1995 Q4 | 312.5 Million USD | 3.2% |
| 1995 Q3 | 302.8 Million USD | 108.68% |
| 1995 Q2 | 145.1 Million USD | 6.77% |
| 1995 FY | 312.5 Million USD | 156.78% |
| 1994 Q2 | 113 Million USD | 6.4% |
| 1994 Q4 | 121.7 Million USD | 4.28% |
| 1994 FY | 121.7 Million USD | 24.18% |
| 1994 Q1 | 106.2 Million USD | 8.37% |
| 1994 Q3 | 116.7 Million USD | 3.27% |
| 1993 Q4 | 98 Million USD | 5.38% |
| 1993 FY | 98 Million USD | 22.96% |
| 1993 Q1 | 85.1 Million USD | 6.78% |
| 1993 Q2 | 88.3 Million USD | 3.76% |
| 1993 Q3 | 93 Million USD | 5.32% |
| 1992 FY | 79.7 Million USD | 109.19% |
| 1992 Q1 | 46.5 Million USD | 22.05% |
| 1992 Q2 | 77.1 Million USD | 65.81% |
| 1992 Q3 | 77.9 Million USD | 1.04% |
| 1992 Q4 | 79.7 Million USD | 2.31% |
| 1991 Q2 | 35.5 Million USD | 0.0% |
| 1991 Q4 | 38.1 Million USD | 5.25% |
| 1991 Q3 | 36.2 Million USD | 1.97% |
| 1991 FY | 38.1 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -778.485% |
| Accuray Incorporated | 468.62 Million USD | -595.633% |
| Align Technology, Inc. | 6.08 Billion USD | 46.417% |
| Elevance Health Inc. | 108.92 Billion USD | 97.007% |
| AxoGen, Inc. | 196.82 Million USD | -1556.239% |
| Boston Scientific Corporation | 35.13 Billion USD | 90.722% |
| CVS Health Corporation | 249.72 Billion USD | 98.695% |
| Cardinal Health, Inc. | 45.12 Billion USD | 92.775% |
| Centene Corporation | 84.64 Billion USD | 96.149% |
| DaVita Inc. | 17.61 Billion USD | 81.498% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 94.201% |
| Hologic, Inc. | 9.15 Billion USD | 64.396% |
| Humana Inc. | 47.06 Billion USD | 93.074% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 80.509% |
| Masimo Corporation | 3.04 Billion USD | -7.181% |
| McKesson Corporation | 67.44 Billion USD | 95.166% |
| Patterson Companies, Inc. | 2.96 Billion USD | -9.796% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 76.751% |
| ResMed Inc. | 6.87 Billion USD | 52.565% |
| Henry Schein, Inc. | 10.57 Billion USD | 69.167% |
| Teladoc Health, Inc. | 4.39 Billion USD | 25.782% |
| Universal Health Services, Inc. | 14.35 Billion USD | 77.294% |
| Veeva Systems Inc. | 5.91 Billion USD | 44.849% |
| Baxter International Inc. | 28.27 Billion USD | 88.471% |
| Becton, Dickinson and Company | 52.78 Billion USD | 93.824% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 78.889% |
| Danaher Corporation | 84.48 Billion USD | 96.142% |
| Stryker Corporation | 39.91 Billion USD | 91.832% |
| Medtronic plc | 89.98 Billion USD | 96.377% |